Clinical Trial

Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

Name: Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region — clinical trial record (NCT07566286)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.

Protocol Amendment History 1 change

critical Recruitment opened 2026-08-15

Trial Details

NCT Number	NCT07566286
Lead Sponsor	Galderma R&D
Conditions	Chin Augmentation
Enrollment	100 participants
Start Date	2026-06-03
Primary Completion	2027-11-01 (estimated)
Study Completion	2028-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-08-14